Citation

Gartner C, Hall W. Int. J. Drug Policy 2015; 26(6): 548-553.

Affiliation

Centre for Youth Substance Abuse Research, The University of Queensland, Herston, QLD 4029, Australia; National Addiction Centre, Kings College London, 4 Windsor Walk, Denmark Hill, London SE5 8BB, United Kingdom.

Copyright

(Copyright © 2015, Elsevier Publishing)

DOI

10.1016/j.drugpo.2015.02.003

PMID

25817484

Abstract

Australia has some of the most restrictive laws concerning use of nicotine in e-cigarettes. The only current legal option for Australians to legally possess and use nicotine for vaping is with a medical prescription and domestic supply is limited to compounding pharmacies that prepare medicines for specific patients. An alternative regulatory option that could be implemented under current drugs and poisons regulations is a 'nicotine licensing' scheme utilising current provisions for 'dangerous poisons'. This commentary discusses how such a scheme could be used to trial access to nicotine solutions for vaping outside of a 'medicines framework' in Australia.

Language: en